Senseonics Holdings Gross Profit | SENS

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:

Raw materials and supplies

Wages of production personnel

Depreciation of equipment

Transportation and warehousing costs (if directly related to production)

Importance for business:

Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales.
Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit.
Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry.
Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.

Reasons for a decline in gross profit:

Increase in raw material and supply costs
Rising production expenses
Price reductions due to competition
Decrease in sales volume
Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit Senseonics Holdings

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
15.8 M	533 K	3.09 M	2.73 M	-811 K	-17.4 M	-19.4 M	-8.15 M	-3.38 M	-328 K	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
15.8 M	-19.4 M	-2.74 M

Quarterly Gross Profit Senseonics Holdings

2026-Q2	2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
8.56 M	6.94 M	3.47 M	3.12 M	1.5 M	-	-4.05 M	298 K	335 K	-	1.17 M	417 K	414 K	-	756 K	824 K	527 K	-	-1.25 M	392 K	526 K	2.58 M	835 K	-1.14 M	-19.6 M	-8.24 M	-3.34 M	-4.55 M	-3.31 M	-4.98 M	-2.58 M	-216 K	-362 K	-1.13 M	-860 K	-900 K	-492 K	-236 K	-77 K	-15 K	-	-	38 K	23 K	15 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
8.56 M	-19.6 M	-632 K

Gross Profit of other stocks in the Diagnostics research industry

Issuer	Gross Profit	Price	% 24h	Market Cap	Country
Biomerica BMRA	362 K	$ 2.46	0.36 %	$ 7.17 M	USA
CareDx, Inc CDNA	81.6 M	$ 61.37	13.0 %	$ 3.27 B	USA
Heska Corporation HSKA	111 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	4.56 M	-	-20.0 %	$ 1.06 M	USA
Co-Diagnostics CODX	400 K	$ 1.15	4.55 %	$ 1.53 M	USA
Castle Biosciences CSTL	53 M	$ 35.19	0.89 %	$ 1.02 B	USA
Danaher Corporation DHR	14.5 B	$ 223.77	0.95 %	$ 159 B	USA
DexCom DXCM	2.8 B	$ 87.47	0.21 %	$ 34.1 B	USA
Fulgent Genetics FLGT	131 M	$ 21.55	1.32 %	$ 663 M	USA
Guardant Health GH	144 M	$ 176.45	0.08 %	$ 22.1 B	USA
ICON Public Limited Company ICLR	817 M	$ 173.9	6.1 %	$ 13.6 B	Irlanda
IDEXX Laboratories IDXX	2.66 B	$ 513.39	0.07 %	$ 41.3 B	USA
IQVIA Holdings IQV	3.79 B	$ 275.02	2.67 %	$ 47.3 B	USA
Laboratory Corporation of America Holdings LH	4.01 B	$ 308.95	1.47 %	$ 25.7 B	USA
Lantheus Holdings LNTH	942 M	$ 99.72	0.01 %	$ 6.73 B	USA
Biodesix BDSX	18.5 M	$ 29.4	0.38 %	$ 222 M	USA
Medpace Holdings MEDP	246 M	$ 620.59	0.56 %	$ 17.9 B	USA
Mettler-Toledo International MTD	2.39 B	$ 1 519.15	1.8 %	$ 31.3 B	Schweiz
Myriad Genetics MYGN	577 M	$ 4.14	3.24 %	$ 383 M	USA
ENDRA Life Sciences NDRA	6.17 K	$ 5.93	2.0 %	$ 4.67 M	USA
NeoGenomics NEO	314 M	$ 19.56	6.54 %	$ 2.51 B	USA
Neogen Corporation NEOG	408 M	$ 13.66	0.66 %	$ 2.97 B	USA
Syneos Health SYNH	4.42 B	-	-	$ 4.46 B	USA
Natera NTRA	127 M	$ 408.79	4.61 %	$ 55.9 B	USA
OPKO Health OPK	206 M	$ 1.64	0.29 %	$ 1.23 B	USA
Anixa Biosciences ANIX	83.8 K	$ 2.78	1.09 %	$ 90.2 K	USA
Motus GI Holdings MOTS	-398 K	-	-34.28 %	$ 263 K	Israel
RadNet RDNT	154 M	$ 71.31	0.04 %	$ 5.36 B	USA
Renalytix AI plc RNLX	156 K	-	5.66 %	$ 22.7 M	Britain
Sotera Health Company SHC	646 M	$ 18.45	0.87 %	$ 5.24 B	USA
Neuronetics STIM	72.3 M	$ 2.82	0.21 %	$ 186 M	USA
Trinity Biotech plc TRIB	21.4 M	$ 6.95	0.68 %	$ 2.5 B	Irlanda
Twist Bioscience Corporation TWST	6.96 M	$ 184.03	16.11 %	$ 11 B	USA
Waters Corporation WAT	1.4 B	$ 430.3	2.31 %	$ 25.6 B	USA
Chembio Diagnostics CEMI	6.58 M	-	0.22 %	$ 16.8 M	USA
Exagen XGN	38.8 M	$ 8.74	2.22 %	$ 188 M	USA
Psychemedics Corporation PMD	7.1 M	-	-1.84 %	$ 15.3 M	USA
T2 Biosystems TTOO	-3.15 M	-	-39.35 %	$ 313 K	USA
DermTech DMTK	276 K	-	-11.32 %	$ 2.94 M	USA
Meridian Bioscience VIVO	188 M	-	-	$ 1.49 B	USA
Akumin AKU	53.5 M	-	-17.87 %	$ 25.9 M	Canada
Accelerate Diagnostics AXDX	2.7 M	-	-61.36 %	$ 2.46 M	USA
Quotient Limited QTNT	14.9 M	-	-11.32 %	$ 1.1 M	Schweiz
Biocept BIOC	6.12 M	-	-13.05 %	$ 7.29 M	USA
BioNano Genomics BNGO	2.77 M	$ 1.69	0.29 %	$ 9.2 M	USA
Burning Rock Biotech Limited BNR	403 M	$ 18.0	19.4 %	$ 194 M	China
Bioventus BVS	388 M	$ 13.52	0.07 %	$ 901 M	USA